(Q44515978)

English

Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension

scientific article published in May 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Zhu Junren

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Thomas Maxwell

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Aldo Rodriguez

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Raul Gamboa

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pablo Gomez-Fernandez

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ginés Ortega-Gonzalez

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Norberta Matadamas

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Freddy Rodriguez

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Badal Dass

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Chris Kyle

11

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Laurent Clarysse

12

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Alfonso Bryce

13

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ernesto Moreno-Heredia

14

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Giuseppe Germano

15

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Leen Gilles

16

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ronald D Smith

17

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

John E Sanderson

18

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

CDSP-944 Study Group

19

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1469-1489

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Labile hypertension: a faulty concept? The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated systolic hypertension: an important cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuation of initial antihypertensive medication after 1 year of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of a losartan-based treatment regimen on isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980133-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80133-9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

release_3vmdfn2jzjg3ddwsiziicbbqfq

1 reference

https://api.fatcat.wiki/v0/release/3vmdfn2jzjg3ddwsiziicbbqfq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44515978&oldid=2026591224"